US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MBX Biosciences

59.02

-1.9200-3.15%

Post-market: 59.880.8600+1.46%16:58 EDT

Volume:306.20K

Turnover:18.28M

Market Cap:2.84B

PE:-24.54

High:61.94

Open:61.75

Low:58.42

Close:60.94

52wk High:72.64

52wk Low:9.63

Shares:48.16M

Float Shares:27.63M

Volume Ratio:0.95

T/O Rate:1.11%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.4052

EPS(LYR):-2.3824

ROE:-33.17%

ROA:-22.08%

PB:6.94

PE(LYR):-24.77

Loading ...

Overview Company News Filings

MBX Biosciences to Present at Morgan Stanley Global Healthcare Conference

MBX Biosciences to Participate in Upcoming Investor Conferences

Mbx Biosciences Announces Appointment of Jeff Held as Chief Legal Officer

THOMSON REUTERS

Press Release: MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer

MBX Biosciences Begins Pivotal Phase 3 Canvuparatide Trial

MBX Biosciences Doses First Patient in Phase 3 oPTimize Trial of Once-Weekly Canvuparatide for Hypoparathyroidism

Mbx Biosciences, - Phase 3 Optimize Trial to Enroll About 160 Adults with Hypoparathyroidism

THOMSON REUTERS

MBX Biosciences Price Target Announced at $88.00/Share by JP Morgan

U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions

13D Filings

Truist Adjusts Price Target on MBX Biosciences to $88 From $70, Maintains Buy Rating

MT Newswires Live

MBX Biosciences, Inc. (MBX) Gets a Buy from Mizuho Securities

MBX Biosciences price target raised to $88 from $70 at Barclays

Analysts Offer Insights on NA Companies: BillionToOne, Inc. Class A (BLLN) and MBX Biosciences, Inc. (MBX)

MBX Biosciences Shares Lower After Q2 Loss Widens

MT Newswires Live

MBX Biosciences, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

MBX Biosciences Advances Canvuparatide and Obesity Pipeline

Earnings Flash (MBX) MBX Biosciences Posts Q2 Net Loss $0.78 a Share, vs. FactSet Est of $0.63 Loss

MT Newswires Live

MBX Biosciences Posts Corporate Presentation on Precision Peptide Programs for Endocrine, Metabolic Diseases

MBX Biosciences Q2 FY26 Net Loss Widens to $37.1 Million; R&D Expenses Rise to $31 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/MBX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MBX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBX\",,,,,undefined,":{"symbol":"MBX","market":"US","secType":"STK","nameCN":"MBX Biosciences","latestPrice":59.02,"timestamp":1789156800000,"preClose":60.94,"halted":0,"volume":306201,"hourTrading":{"tag":"盘后","latestPrice":59.88,"preClose":59.02,"latestTime":"16:58 EDT","volume":10336,"amount":610032.47712,"timestamp":1789160305873,"change":0.86,"changeRate":0.014571,"amplitude":0.014571},"delay":0,"changeRate":-0.03150639973744658,"floatShares":27629899,"shares":48160096,"eps":-2.4052,"marketStatus":"Post-Mkt","change":-1.92,"latestTime":"09-11 17:13:41 EDT","open":61.75,"high":61.94,"low":58.42,"amount":18279815.723946,"amplitude":0.057762,"askPrice":60.17,"askSize":33,"bidPrice":57.87,"bidSize":34,"shortable":3,"etf":0,"ttmEps":-2.4052,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789171200000},"marketStatusCode":4,"adr":0,"listingDate":1726200000000,"exchange":"NASDAQ","adjPreClose":60.94,"preHourTrading":{"tag":"盘前","latestPrice":61.56,"preClose":60.94,"latestTime":"09:09 EDT","volume":725,"amount":44204.08085,"timestamp":1789132174286,"change":0.62,"changeRate":0.010174,"amplitude":0.036757},"postHourTrading":{"tag":"盘后","latestPrice":59.88,"preClose":59.02,"latestTime":"16:58 EDT","volume":10336,"amount":610032.47712,"timestamp":1789160305873,"change":0.86,"changeRate":0.014571,"amplitude":0.014571},"volumeRatio":0.954725,"impliedVol":0.9951,"impliedVolPercentile":0.6733},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBX\",,,,,undefined,":{"symbol":"MBX","floatShares":27629899,"roa":"-22.08%","roe":"-33.17%","lyrEps":-2.382369,"volumeRatio":0.954725,"shares":48160096,"dividePrice":0,"high":61.94,"amplitude":0.057762,"preClose":60.94,"low":58.42,"week52Low":9.63,"pbRate":"6.94","week52High":72.64,"institutionHeld":0,"latestPrice":59.02,"committee":0.014925,"eps":-2.4052,"divideRate":0,"volume":306201,"delay":0,"ttmEps":-2.4052,"open":61.75,"prevYearClose":31.54,"prevWeekClose":61.72,"prevMonthClose":61.6,"prevQuarterClose":55.2,"fiveDayClose":61.42,"twentyDayClose":67.08,"sixtyDayClose":40.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MBX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"MBX","fiscalQuarterEnding":"2026/06","expectedEps":-0.68,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.78},{"market":"US","date":"2026-05-07","symbol":"MBX","fiscalQuarterEnding":"2026/03","expectedEps":-0.62,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.51},{"market":"US","date":"2026-03-12","symbol":"MBX","fiscalQuarterEnding":"2025/12","expectedEps":-0.64,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"pre","actualEps":-0.49},{"market":"US","date":"2025-11-06","symbol":"MBX","fiscalQuarterEnding":"2025/09","expectedEps":-0.73,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.63},{"market":"US","date":"2025-08-07","symbol":"MBX","fiscalQuarterEnding":"2025/06","expectedEps":-0.77,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.58}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MBX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MBX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":12,"updateTime":1787371200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MBX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MBX","date":"2026-09-10","current":-24.5385,"percent":0.088176,"low":-38.854907,"twenty":-19.254278,"median":-13.751441,"eighty":-5.782152,"high":-3.125337,"avg":-13.927577,"sd":8.346501,"marketCap":3029751639},"quantilePoints":[{"date":"2024-09-13","current":-15.960592,"twenty":-13.895501,"median":-10.797864,"eighty":-10.797864,"marketCap":753339957},{"date":"2024-09-20","current":-15.949203,"twenty":-15.694582,"median":-15.111074,"eighty":-12.419885,"marketCap":752802389},{"date":"2024-09-27","current":-16.939398,"twenty":-16.33255,"median":-15.751164,"eighty":-14.917986,"marketCap":799539567},{"date":"2024-10-04","current":-16.797941,"twenty":-16.986079,"median":-16.110499,"eighty":-15.091977,"marketCap":792862827},{"date":"2024-10-11","current":-16.932325,"twenty":-16.986079,"median":-16.31699,"eighty":-15.248994,"marketCap":799205730},{"date":"2024-10-18","current":-17.024271,"twenty":-17.032759,"median":-16.518565,"eighty":-15.369232,"marketCap":803545610},{"date":"2024-10-25","current":-15.022664,"twenty":-17.021442,"median":-16.380645,"eighty":-15.369232,"marketCap":709069745},{"date":"2024-11-01","current":-15.885548,"twenty":-16.991737,"median":-16.362963,"eighty":-15.369232,"marketCap":749797857},{"date":"2024-11-08","current":-13.874718,"twenty":-16.947885,"median":-16.309917,"eighty":-15.248994,"marketCap":765593046},{"date":"2024-11-15","current":-10.66494,"twenty":-16.936569,"median":-16.143706,"eighty":-14.480386,"marketCap":588480730},{"date":"2024-11-22","current":-11.203941,"twenty":-16.918179,"median":-15.949203,"eighty":-13.805677,"marketCap":618222233},{"date":"2024-11-29","current":-12.318278,"twenty":-16.877157,"median":-15.751164,"eighty":-12.380051,"marketCap":679710282},{"date":"2024-12-06","current":-13.432616,"twenty":-16.771064,"median":-15.461179,"eighty":-11.837418,"marketCap":741198331},{"date":"2024-12-13","current":-11.470413,"twenty":-16.663558,"median":-15.31265,"eighty":-11.837418,"marketCap":632925896},{"date":"2024-12-20","current":-12.330391,"twenty":-16.662143,"median":-15.019127,"eighty":-11.803503,"marketCap":680378630},{"date":"2024-12-27","current":-12.154761,"twenty":-16.656485,"median":-14.542475,"eighty":-11.803503,"marketCap":670687579},{"date":"2025-01-03","current":-11.258446,"twenty":-16.435813,"median":-14.054537,"eighty":-11.676323,"marketCap":621229800},{"date":"2025-01-10","current":-8.290916,"twenty":-16.380645,"median":-13.850493,"eighty":-11.492215,"marketCap":457484452},{"date":"2025-01-17","current":-5.989566,"twenty":-16.372157,"median":-13.75965,"eighty":-11.117943,"marketCap":330498264},{"date":"2025-01-24","current":-6.510398,"twenty":-16.36367,"median":-13.256987,"eighty":-10.797864,"marketCap":359237243},{"date":"2025-01-31","current":-6.06224,"twenty":-16.342452,"median":-12.878476,"eighty":-9.893382,"marketCap":334508354},{"date":"2025-02-07","current":-7.473331,"twenty":-16.314161,"median":-12.457571,"eighty":-8.809325,"marketCap":412370938},{"date":"2025-02-14","current":-6.304488,"twenty":-16.290113,"median":-12.324334,"eighty":-7.444262,"marketCap":347875321},{"date":"2025-02-21","current":-6.589128,"twenty":-16.247676,"median":-12.215323,"eighty":-7.171733,"marketCap":363581507},{"date":"2025-02-28","current":-5.813937,"twenty":-16.175534,"median":-12.009413,"eighty":-6.798672,"marketCap":320807212},{"date":"2025-03-07","current":-5.989566,"twenty":-16.064646,"median":-11.803503,"eighty":-6.591551,"marketCap":330498264},{"date":"2025-03-14","current":-5.26888,"twenty":-15.958314,"median":-11.682379,"eighty":-6.514032,"marketCap":290731536},{"date":"2025-03-21","current":-4.258879,"twenty":-15.936472,"median":-11.549143,"eighty":-6.294798,"marketCap":263718287},{"date":"2025-03-28","current":-4.188707,"twenty":-15.858671,"median":-11.258446,"eighty":-6.213645,"marketCap":259373118},{"date":"2025-04-04","current":-3.260282,"twenty":-15.749749,"median":-11.107042,"eighty":-6.057395,"marketCap":201883200},{"date":"2025-04-11","current":-3.999783,"twenty":-15.687509,"median":-10.797864,"eighty":-5.922948,"marketCap":247674589},{"date":"2025-04-17","current":-4.113138,"twenty":-15.461179,"median":-10.66494,"eighty":-5.686757,"marketCap":254693707},{"date":"2025-04-25","current":-4.949799,"twenty":-15.461179,"median":-9.901861,"eighty":-5.438453,"marketCap":306501482},{"date":"2025-05-02","current":-6.477382,"twenty":-15.454106,"median":-9.653557,"eighty":-5.327647,"marketCap":401092452},{"date":"2025-05-09","current":-5.996976,"twenty":-15.31265,"median":-8.539219,"eighty":-5.438453,"marketCap":371344761},{"date":"2025-05-16","current":-5.077465,"twenty":-15.206557,"median":-7.473331,"eighty":-5.077465,"marketCap":373015980},{"date":"2025-05-23","current":-5.691675,"twenty":-15.022664,"median":-7.246225,"eighty":-5.226487,"marketCap":418138881},{"date":"2025-05-30","current":-5.787218,"twenty":-15.017006,"median":-7.134185,"eighty":-5.260401,"marketCap":425157999},{"date":"2025-06-06","current":-5.395944,"twenty":-14.885451,"median":-6.813207,"eighty":-5.315894,"marketCap":396413040},{"date":"2025-06-13","current":-4.877278,"twenty":-14.35621,"median":-6.707223,"eighty":-5.172099,"marketCap":358309257},{"date":"2025-06-20","current":-4.677092,"twenty":-14.130289,"median":-6.595185,"eighty":-5.059804,"marketCap":343602533},{"date":"2025-06-27","current":-5.136611,"twenty":-14.052953,"median":-6.564904,"eighty":-5.017962,"marketCap":377361148},{"date":"2025-07-03","current":-5.673476,"twenty":-13.977856,"median":-6.515167,"eighty":-5.013234,"marketCap":416801906},{"date":"2025-07-11","current":-5.641628,"twenty":-13.855338,"median":-6.4303,"eighty":-5.035235,"marketCap":414462200},{"date":"2025-07-18","current":-5.548359,"twenty":-13.804466,"median":-6.320845,"eighty":-5.055522,"marketCap":407610204},{"date":"2025-07-25","current":-5.928259,"twenty":-13.766918,"median":-6.298431,"eighty":-5.072006,"marketCap":435519554},{"date":"2025-08-01","current":-6.028352,"twenty":-13.628836,"median":-6.310434,"eighty":-5.101123,"marketCap":442872915},{"date":"2025-08-08","current":-4.830149,"twenty":-13.362364,"median":-6.283291,"eighty":-5.101123,"marketCap":372013249},{"date":"2025-08-15","current":-5.76189,"twenty":-13.198847,"median":-6.22399,"eighty":-5.101123,"marketCap":443774969},{"date":"2025-08-22","current":-6.171895,"twenty":-13.089836,"median":-6.221845,"eighty":-5.14935,"marketCap":475353203},{"date":"2025-08-29","current":-6.224236,"twenty":-12.914207,"median":-6.224236,"eighty":-5.170279,"marketCap":479384467},{"date":"2025-09-05","current":-5.635398,"twenty":-12.685283,"median":-6.241684,"eighty":-5.176649,"marketCap":434032748},{"date":"2025-09-12","current":-4.331231,"twenty":-12.593229,"median":-6.221845,"eighty":-5.070186,"marketCap":333587089},{"date":"2025-09-19","current":-4.392296,"twenty":-12.449092,"median":-6.213645,"eighty":-5.008506,"marketCap":338290230},{"date":"2025-09-26","current":-10.057984,"twenty":-12.39822,"median":-6.217295,"eighty":-5.008506,"marketCap":774655869},{"date":"2025-10-03","current":-9.721364,"twenty":-12.327968,"median":-6.224236,"eighty":-5.029502,"marketCap":748729706},{"date":"2025-10-10","current":-9.207959,"twenty":-12.309799,"median":-6.253122,"eighty":-5.039662,"marketCap":709187798},{"date":"2025-10-17","current":-7.994552,"twenty":-12.25166,"median":-6.280939,"eighty":-5.051241,"marketCap":615732407},{"date":"2025-10-24","current":-9.364715,"twenty":-12.13417,"median":-6.307461,"eighty":-5.070186,"marketCap":721260982},{"date":"2025-10-31","current":-12.650784,"twenty":-12.13417,"median":-6.352937,"eighty":-5.089294,"marketCap":974350701},{"date":"2025-11-07","current":-13.743232,"twenty":-12.309799,"median":-6.369154,"eighty":-5.142981,"marketCap":1106261420},{"date":"2025-11-14","current":-13.426901,"twenty":-12.512852,"median":-6.477382,"eighty":-5.169369,"marketCap":1080798409},{"date":"2025-11-21","current":-15.07807,"twenty":-12.739549,"median":-6.521866,"eighty":-5.176649,"marketCap":1213709223},{"date":"2025-11-28","current":-19.239461,"twenty":-13.256987,"median":-6.567932,"eighty":-5.191208,"marketCap":1548680395},{"date":"2025-12-05","current":-17.036043,"twenty":-13.72255,"median":-6.589128,"eighty":-5.211681,"marketCap":1371316303},{"date":"2025-12-12","current":-15.859028,"twenty":-13.826268,"median":-6.619611,"eighty":-5.226487,"marketCap":1276572445},{"date":"2025-12-19","current":-15.992906,"twenty":-14.046615,"median":-6.70403,"eighty":-5.26888,"marketCap":1287348998},{"date":"2025-12-26","current":-17.911832,"twenty":-14.268105,"median":-6.806351,"eighty":-5.279538,"marketCap":1441812917},{"date":"2026-01-02","current":-17.59387,"twenty":-14.917986,"median":-6.813207,"eighty":-5.295223,"marketCap":1416218605},{"date":"2026-01-09","current":-17.136452,"twenty":-15.146199,"median":-7.076651,"eighty":-5.307262,"marketCap":1379398717},{"date":"2026-01-16","current":-22.820712,"twenty":-15.452731,"median":-7.200803,"eighty":-5.317689,"marketCap":1836953174},{"date":"2026-01-23","current":-23.646296,"twenty":-15.472295,"median":-7.424882,"eighty":-5.324948,"marketCap":1903408581},{"date":"2026-01-30","current":-20.550355,"twenty":-15.847871,"median":-7.61062,"eighty":-5.334947,"marketCap":1654200805},{"date":"2026-02-06","current":-20.109671,"twenty":-15.97998,"median":-7.994552,"eighty":-5.365916,"marketCap":1618727987},{"date":"2026-02-13","current":-22.260078,"twenty":-16.085028,"median":-8.265761,"eighty":-5.405044,"marketCap":1791824944},{"date":"2026-02-20","current":-21.826592,"twenty":-16.300015,"median":-8.354645,"eighty":-5.422333,"marketCap":1756931510},{"date":"2026-02-27","current":-20.526135,"twenty":-16.365085,"median":-8.65641,"eighty":-5.437203,"marketCap":1652251211},{"date":"2026-03-06","current":-18.414356,"twenty":-16.656674,"median":-8.777334,"eighty":-5.439664,"marketCap":1482263608},{"date":"2026-03-13","current":-15.268438,"twenty":-16.663558,"median":-8.888641,"eighty":-5.448143,"marketCap":1327911291},{"date":"2026-03-20","current":-15.530651,"twenty":-16.662191,"median":-9.207959,"eighty":-5.4632,"marketCap":1350716208},{"date":"2026-03-27","current":-15.454172,"twenty":-16.656674,"median":-9.44019,"eighty":-5.477809,"marketCap":1344064774},{"date":"2026-04-02","current":-17.639279,"twenty":-16.656721,"median":-9.686541,"eighty":-5.527885,"marketCap":1534105746},{"date":"2026-04-10","current":-17.950657,"twenty":-16.797941,"median":-9.847355,"eighty":-5.527885,"marketCap":1561186584},{"date":"2026-04-17","current":-18.147317,"twenty":-16.939398,"median":-9.944254,"eighty":-5.546084,"marketCap":1578290272},{"date":"2026-04-24","current":-18.240184,"twenty":-16.993812,"median":-10.091627,"eighty":-5.548359,"marketCap":1586367013},{"date":"2026-05-01","current":-16.529418,"twenty":-17.017199,"median":-10.162452,"eighty":-5.565633,"marketCap":1437580056},{"date":"2026-05-08","current":-19.051466,"twenty":-17.024271,"median":-10.419594,"eighty":-5.573382,"marketCap":1651171534},{"date":"2026-05-15","current":-19.432949,"twenty":-17.098465,"median":-10.797864,"eighty":-5.623429,"marketCap":1683048872},{"date":"2026-05-22","current":-17.470969,"twenty":-17.116218,"median":-10.949581,"eighty":-5.635398,"marketCap":1513125669},{"date":"2026-05-29","current":-17.531422,"twenty":-17.244113,"median":-11.182744,"eighty":-5.640382,"marketCap":1518361398},{"date":"2026-06-05","current":-16.987343,"twenty":-17.244113,"median":-11.332873,"eighty":-5.647113,"marketCap":1471239837},{"date":"2026-06-12","current":-20.471645,"twenty":-17.244113,"median":-11.549143,"eighty":-5.650278,"marketCap":1773008216},{"date":"2026-06-18","current":-22.856798,"twenty":-17.305607,"median":-11.667238,"eighty":-5.653457,"marketCap":1979581522},{"date":"2026-06-26","current":-27.68206,"twenty":-17.435508,"median":-11.803503,"eighty":-5.659497,"marketCap":2397487888},{"date":"2026-07-02","current":-30.732198,"twenty":-17.480357,"median":-11.965702,"eighty":-5.666777,"marketCap":2661654213},{"date":"2026-07-10","current":-36.112531,"twenty":-17.527026,"median":-11.991245,"eighty":-5.673476,"marketCap":3127634090},{"date":"2026-07-17","current":-32.051177,"twenty":-17.634503,"median":-12.154761,"eighty":-5.678788,"marketCap":2775888299},{"date":"2026-07-24","current":-34.936442,"twenty":-17.867538,"median":-12.324334,"eighty":-5.688724,"marketCap":3025775363},{"date":"2026-07-31","current":-36.524712,"twenty":-17.911832,"median":-12.436374,"eighty":-5.691675,"marketCap":3163332242},{"date":"2026-08-07","current":-30.628146,"twenty":-17.994359,"median":-12.627144,"eighty":-5.692585,"marketCap":3194270640},{"date":"2026-08-14","current":-30.97629,"twenty":-18.158049,"median":-12.72465,"eighty":-5.698044,"marketCap":3230579239},{"date":"2026-08-21","current":-30.63919,"twenty":-18.368939,"median":-13.111638,"eighty":-5.710784,"marketCap":3195422369},{"date":"2026-08-28","current":-30.657661,"twenty":-18.452139,"median":-13.429759,"eighty":-5.738476,"marketCap":3197348773},{"date":"2026-09-04","current":-28.362608,"twenty":-19.064304,"median":-13.72255,"eighty":-5.766956,"marketCap":2957993096},{"date":"2026-09-10","current":-29.050662,"twenty":-19.254278,"median":-13.751441,"eighty":-5.782152,"marketCap":3029751639}],"updateTime":1789161221842},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MBX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666389205","title":"MBX Biosciences to Present at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666389205","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666389205?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:08","pubTimestamp":1788955685,"startTime":"0","endTime":"0","summary":"MBX Biosciences to present at Morgan Stanley Global Healthcare ConferenceMBX Biosciences will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Sept. 16, 2026 in New York.Manag","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL2hB8Zp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0267386448.USD","LU1732800096.USD","LU0158827781.USD","LU1791710400.SGD","LU1244550494.USD","LU1244550577.SGD","LU2347655156.SGD","LU1064131342.USD","BK4534","LU2271345857.HKD","LU1074936037.SGD","IE00B64PRP62.GBP","SF","SG9999014005.SGD","IE00BQXX3F31.USD","LU1668664300.SGD","LU2264538146.SGD","LU2095319765.USD","LU2089283258.USD","IE00BQXX3D17.EUR","LU0795875169.SGD","BK4504","LU1548497426.USD","IE00BGHQF748.EUR","LU1989772840.SGD","LU1720051017.SGD","LU2133065610.SGD","BK4581","LU2111349929.HKD","NDAQ","LU2357305700.SGD","LU2487616109.SGD","IE00BKPKM429.USD","LU0225283273.USD","SG9999014013.SGD","LU0106261372.USD","LU0106831901.USD","IE00B3QW5Z07.USD","IE00B3S45H60.SGD","BK4007","BK4588","LU0320765646.SGD","LU0557290698.USD","IAI","IE00BN0W2W23.USD","BCDF","IE00BZ1G4Q59.USD","KBWB","SG9999014039.USD","MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533169","title":"MBX Biosciences to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533169","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533169?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955200,"startTime":"0","endTime":"0","summary":"CARMEL, Ind., and BURLINGTON, Mass., Sept.  09, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and comme","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358552/0/en/mbx-biosciences-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320319","title":"Mbx Biosciences Announces Appointment of Jeff Held as Chief Legal Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320319","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320319?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:00","pubTimestamp":1788868805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA8QWKM5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320366","title":"Press Release: MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320366","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320366?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:00","pubTimestamp":1788868800,"startTime":"0","endTime":"0","summary":"CARMEL, Ind. and BURLINGTON, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commerc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4604","BK4585","BK4555","TM","BK4099","MBX","03160","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662001117","title":"MBX Biosciences Begins Pivotal Phase 3 Canvuparatide Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662001117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662001117?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:58","pubTimestamp":1787835530,"startTime":"0","endTime":"0","summary":"MBX Biosciences, Inc. ( ($MBX) ) just unveiled an update. On August 27, 2026, MBX Biosciences announced that the first patient had been dosed in it...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mbx-biosciences-begins-pivotal-phase-3-canvuparatide-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mbx-biosciences-begins-pivotal-phase-3-canvuparatide-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MBX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662970289","title":"MBX Biosciences Doses First Patient in Phase 3 oPTimize Trial of Once-Weekly Canvuparatide for Hypoparathyroidism","url":"https://stock-news.laohu8.com/highlight/detail?id=2662970289","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662970289?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:00","pubTimestamp":1787832053,"startTime":"0","endTime":"0","summary":"MBX Biosciences doses first patient in Phase 3 oPTimize trial of once-weekly canvuparatide for hypoparathyroidismMBX Biosciences started dosing patients in its pivotal Phase 3 oPTimize trial of once-w","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL1HDw35:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3C00.GBP","BK4007","BK4588","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BN0W2W23.USD","SG9999014013.SGD","BK4112","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014021.USD","SG9999014005.SGD","MBX","NDAQ","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU2210149790.SGD","IE00BQXX3F31.USD","IE00BGHQF748.EUR","LU2095319765.USD","BCDF","LU0314104364.USD","SG9999014039.USD","IE00BQXX3D17.EUR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662704077","title":"Mbx Biosciences, - Phase 3 Optimize Trial to Enroll About 160 Adults with Hypoparathyroidism","url":"https://stock-news.laohu8.com/highlight/detail?id=2662704077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662704077?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:00","pubTimestamp":1787832002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA9JP4QW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661924292","title":"MBX Biosciences Price Target Announced at $88.00/Share by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2661924292","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661924292?lang=en_us&edition=fundamental","pubTime":"2026-08-22 03:12","pubTimestamp":1787339520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MBX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250734","title":"U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250734?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:26","pubTimestamp":1787297213,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Health Catalyst, Nektar Therapeutics, TIC SolutionsAug 21 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, incl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL8N44I09H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EGGY","LEGR","AMD","VEGI","CTEV","DISK","AMP","MCHP","MTSI","INNV","ACEL","P","AAP","ECG","FTAI","QBTS","FERG","SMHX","HCAT","IXN","LMB","ADSK","FIX","MBX","BCAL","MRVL","ABT","EBS","GTLB","IMA","HL","BAI","LYTS","PI","APP","MATW","COTY","DE","DV","FTH","MU","AVGU","AVGO","ADI","AMYY","HRZN","BWMN","CHAT","TRFK","DOCS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659122699","title":"13D Filings","url":"https://stock-news.laohu8.com/highlight/detail?id=2659122699","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659122699?lang=en_us&edition=fundamental","pubTime":"2026-08-15 07:06","pubTimestamp":1786748760,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequen","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4116","BK4228","BK4082","BK4007","MBX","BK4215","UMH","BK4608","CORZ","BK4023","SI","GTE","BK4211","STCE","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658398734","title":"Truist Adjusts Price Target on MBX Biosciences to $88 From $70, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2658398734","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658398734?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:11","pubTimestamp":1786356711,"startTime":"0","endTime":"0","summary":"MBX Biosciences (MBX) has an average rating of buy and mean price target of $88.40, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657362993","title":"MBX Biosciences, Inc. (MBX) Gets a Buy from Mizuho Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2657362993","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657362993?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:55","pubTimestamp":1786136131,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Uy Ear reiterated a Buy rating on MBX Biosciences, Inc. today and set a price target of $91.00. According to TipRanks, Ea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mbx-biosciences-inc-mbx-gets-a-buy-from-mizuho-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mbx-biosciences-inc-mbx-gets-a-buy-from-mizuho-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MFG","BK4007","MBX","BK4207","GSIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657612918","title":"MBX Biosciences price target raised to $88 from $70 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2657612918","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657612918?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:21","pubTimestamp":1786098101,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on MBX Biosciences (MBX) to $88 from $70 and keeps an Overweight rating on the shares. The firm updated the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mbx-biosciences-price-target-raised-to-88-from-70-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mbx-biosciences-price-target-raised-to-88-from-70-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656758","title":"Analysts Offer Insights on NA Companies: BillionToOne, Inc. Class A (BLLN) and MBX Biosciences, Inc. (MBX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656758","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657656758?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:50","pubTimestamp":1786035024,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on BillionToOne, Inc. Class A (BLLN) and MBX Biosciences, Inc. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-billiontoone-inc-class-a-blln-and-mbx-biosciences-inc-mbx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-billiontoone-inc-class-a-blln-and-mbx-biosciences-inc-mbx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MBX","BLLN","NA","BK4007","BK4196","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657180658","title":"MBX Biosciences Shares Lower After Q2 Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2657180658","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657180658?lang=en_us&edition=fundamental","pubTime":"2026-08-06 22:40","pubTimestamp":1786027259,"startTime":"0","endTime":"0","summary":"MBX Biosciences  shares were about 1.0% lower in Thursday trading following its Q2 results.Earlier, the clinical-stage biopharmaceutical company reported a Q2 net loss of $0.78 per share, compared with a loss of $0.58 a year ago.Looking ahead, the firm said its cash and investments are expected to support operations into 2029.Price: 66.78, Change: -0.70, Percent Change: -1.04","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MBX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657541637","title":"MBX Biosciences, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657541637","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657541637?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:47","pubTimestamp":1786024062,"startTime":"0","endTime":"0","summary":"MBX Biosciences, Inc. reports results for the quarter ended June 30 - Earnings SummaryMBX Biosciences, Inc.MBX.OQreported a quarterly adjusted loss of 78 cents per share for the quarter ended June 30,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N443229:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657118631","title":"MBX Biosciences Advances Canvuparatide and Obesity Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2657118631","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657118631?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:41","pubTimestamp":1786020108,"startTime":"0","endTime":"0","summary":"An announcement from MBX Biosciences, Inc. ( ($MBX) ) is now available. MBX Biosciences reported its second-quarter 2026 results on August 6, 2026,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mbx-biosciences-advances-canvuparatide-and-obesity-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mbx-biosciences-advances-canvuparatide-and-obesity-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MBX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657063991","title":"Earnings Flash (MBX) MBX Biosciences Posts Q2 Net Loss $0.78 a Share, vs. FactSet Est of $0.63 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2657063991","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657063991?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:12","pubTimestamp":1786018336,"startTime":"0","endTime":"0","summary":"Earnings Flash (MBX) MBX Biosciences Posts Q2 Net Loss $0.78 a Share, vs. FactSet Est of $0.63 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657639558","title":"MBX Biosciences Posts Corporate Presentation on Precision Peptide Programs for Endocrine, Metabolic Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2657639558","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657639558?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:11","pubTimestamp":1786018268,"startTime":"0","endTime":"0","summary":"MBX Biosciences posts corporate presentation on precision peptide programs for endocrine, metabolic diseasesMBX Biosciences outlined a catalyst schedule led by canvuparatide (MBX 2109) Phase 3 initiat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL7Xfsrm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657563989","title":"MBX Biosciences Q2 FY26 Net Loss Widens to $37.1 Million; R&D Expenses Rise to $31 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657563989","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657563989?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:08","pubTimestamp":1786018099,"startTime":"0","endTime":"0","summary":"MBX Biosciences Q2 FY26 net loss widens to $37.1 million; R&D expenses rise to $31 millionMBX Biosciences posted a Q2 net loss of USD 37.1 million, widening from USD 19.4 million a year earlier.R&D ex","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL3ctvVZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":106,"code":"91000000","status":"200"}]}}